100
Participants
Start Date
April 30, 2024
Primary Completion Date
April 30, 2026
Study Completion Date
October 31, 2026
Limosilactobacillus reuteri
"The BioGaia® Gastrus probiotic capsule contains the following components: L. reuteri DSM 17938, L. reuteri ATCC PTA 6475) at 10\^8 CFU\*/day, fully hydrogenated palm oil; ascorbic acid; tangerine flavour and mint flavour.~\*Colony forming Unit"
Placebo
The placebo capsules have the same external appearance and composition as the BioGaia® Gastrus Limosilactobacillus reuteri probiotic capsule (combination of L. reuteri DSM 17938 and L. reuteri ATCC PTA 6475), but without the active ingredient.
Centre Hospitalier Universitaire de Martinique - Hôpital Pierre ZOBDA QUITMAN, Fort-de-France
Collaborators (1)
BioGaia AB
INDUSTRY
University Hospital, Limoges
OTHER
Regional Health Agency, Martinique
UNKNOWN
Biological Resource Centre, Martinique
UNKNOWN
Reims University hospital
OTHER
University Hospital Center of Martinique
OTHER